newsfilter
← Latest News
GlobeNewswire·

Viela Bio Reports Third Quarter 2019 Financial Results and Business Highlights

GAITHERSBURG, Md., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today...